Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
PUMA BIOTECHNOLOGY, INC. has filed 1,115 SEC EDGAR filings since 14 Sep 2007

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
PRER14A File 001-35703

PRER14A

Filing date
09 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-35703

PRER14A

Filing date
07 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-35703

DFAN14A

Filing date
07 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35703

DEFA14A

Filing date
04 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-35703

PRER14A

Filing date
04 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
01 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-35703

DFAN14A

Filing date
30 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
30 Nov 2015
Reporting date
30 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
PREC14A File 001-35703

PREC14A

Filing date
23 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

8-K

Filing date
19 Nov 2015
Reporting date
18 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35703

8-K

Filing date
19 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFC14A File 001-35703

DEFINITIVE CONSENT STATEMENT

Filing date
18 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRRN14A File 001-35703

SECOND REVISED PRELIMINARY CONSENT STATEMENT

Filing date
17 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRRN14A File 001-35703

REVISED PRELIMINARY CONSENT STATEMENT

Filing date
10 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
09 Nov 2015
Reporting date
09 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-35703

DFAN14A

Filing date
03 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

8-K

Filing date
02 Nov 2015
Reporting date
28 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35703

8-K

Filing date
02 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .